These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12838500)

  • 1. The relationship of cigarette smoking to end-stage renal disease.
    Wesson DE
    Semin Nephrol; 2003 May; 23(3):317-22. PubMed ID: 12838500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study.
    Afifi A; El Setouhy M; El Sharkawy M; Ali M; Ahmed H; El-Menshawy O; Masoud W
    East Mediterr Health J; 2004; 10(4-5):620-6. PubMed ID: 16335654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different regional dynamics of end-stage renal disease in Japan by different causes.
    Kato N; Usami T; Fukuda M; Motokawa M; Kamiya Y; Yoshida A; Kimura G
    Nephrology (Carlton); 2005 Aug; 10(4):400-4. PubMed ID: 16109089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking--an emerging risk factor for renal diseases.
    McLigeyo SO
    East Afr Med J; 1998 Mar; 75(3):171-4. PubMed ID: 9640817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of change of end-stage renal disease treatment incidence 1978-1987--has there been selection?
    Rosansky SJ; Jackson K
    J Am Soc Nephrol; 1992 Apr; 2(10):1502-6. PubMed ID: 1600122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial factors in the incidence and causation of end-stage renal disease (ESRD).
    Easterling RE
    Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension].
    Palmer AJ; Annemans L; Roze S; Lamotte M; Rodby RA; Ritz E
    Dtsch Med Wochenschr; 2004 Jan; 129(1-2):13-8. PubMed ID: 14703575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the stages of chronic kidney disease.
    Castner D
    Nursing; 2010 May; 40(5):24-31; quiz 31-2. PubMed ID: 20386393
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-stage renal disease: a southern epidemic.
    Moore MA
    South Med J; 1994 Oct; 87(10):1013-7. PubMed ID: 7939913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and progression of CRF in Iceland: a population-based study.
    Magnason RL; Indridason OS; Sigvaldason H; Sigfusson N; Palsson R
    Am J Kidney Dis; 2002 Nov; 40(5):955-63. PubMed ID: 12407640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved understanding of the causes of end-stage renal disease.
    Young EW
    Semin Nephrol; 1997 May; 17(3):170-5. PubMed ID: 9165646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complication in diabetic nephropathy.
    John S
    Diabetes Metab Syndr; 2016; 10(4):247-249. PubMed ID: 27389078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-stage renal disease in Nigeria: an overview of the epidemiology and the pathogenetic mechanisms.
    Odubanjo MO; Okolo CA; Oluwasola AO; Arije A
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1064-71. PubMed ID: 21912052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and progression of diabetic nephropathy in patients with type 1 diabetes.
    Feodoroff M; Harjutsalo V; Forsblom C; Thorn L; Wadén J; Tolonen N; Lithovius R; Groop PH
    Acta Diabetol; 2016 Aug; 53(4):525-33. PubMed ID: 26668013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
    Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
    J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in incidence of end-stage renal failure in Australia, 1972-1991.
    Stewart JH; McCredie M; Disney AP; Mathew TH
    Nephrol Dial Transplant; 1994; 9(10):1377-82. PubMed ID: 7816248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.